Aging is a natural process, yixue anti-aging, refers to some with inhibition, delay the aging process of the body, can promote the overall health, make the body in the genetic factors within the life limit to maintain a better intelligence and physical strength.Aging, however much you may be reluctant to do it, is a natural part of life.Skin can appear as the lapse of years a variety of problems are like furrow, flabby, chromatic spot, dark dumb etc.Anti-aging is to help reduce the production of free radicals and increase skin elasticity by supplementing antioxidant substances, while supplementing collagen or enzyme, anti-aging dietary therapy and anti-aging skin care products can effectively delay aging.
This report contains market size and forecasts of Longevity and Anti-senescence Therapy in Global, including the following market information:
Global Longevity and Anti-senescence Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Longevity and Anti-senescence Therapy market was valued at 327.6 million in 2021 and is projected to reach US$ 552.4 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hemolytic Drug Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Longevity and Anti-senescence Therapy include CohBar, TA Sciences, Unity Biotechnology, AgeX Therapeutics，Inc and PowerVision Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Longevity and Anti-senescence Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Longevity and Anti-senescence Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Longevity and Anti-senescence Therapy Market Segment Percentages, by Type, 2021 (%)
Hemolytic Drug Therapy
Gene Therapy
Immunotherapy
Other Stem Cell Therapies
Global Longevity and Anti-senescence Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Longevity and Anti-senescence Therapy Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical Service Institution
Drug and Device Sales
Global Longevity and Anti-senescence Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Longevity and Anti-senescence Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Longevity and Anti-senescence Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Longevity and Anti-senescence Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CohBar
TA Sciences
Unity Biotechnology
AgeX Therapeutics，Inc
PowerVision Inc.